[5-hydroxytryptamine and neoplasm growth].
D000310:Adrenal Gland Neoplasms / Q000378:metabolism; D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism; D001984:Bronchial Neoplasms / Q000378:metabolism; D002276:Carcinoid Tumor / Q000378:metabolism; D002648:Child; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000378:metabolism; D006801:Humans; D007938:Leukemia / Q000378:metabolism; D008175:Lung Neoplasms / Q000378:metabolism; D016403:Lymphoma, Large B-Cell, Diffuse / Q000378:metabolism; D008297:Male; D008545:Melanoma / Q000378:metabolism; D051379:Mice; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009447:Neuroblastoma / Q000378:metabolism; D010673:Pheochromocytoma / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000378:metabolism; D001749:Urinary Bladder Neoplasms / Q000378:metabolism
D012701:Serotonin
5-oksitriptamin i opukholevoĭ rost.